Abstract:Objective To explore the neuroprotective effects of DADLE ([D-Ala2,D-Leu5]-enkephalin) on total cerebral ischemia in rats. Methods Sixty adult healthy male Sprague-Dawley rats were randomly divided into six groups (n=10): sham operation group (sham), artificial cerebral spinal fluid group (ACSF), DADLE 0.2 mmol/L group (DAD0.2), DADLE 2 mmol/L group (DAD2), DADLE 20 mmol/L group (DAD20) and DADLE 2 mmol/L+naltrindole 2 mmol/L group (DAD2+N). With a stereotaxic instrument, the above mentioned solution (10 μL) was injected into the left lateral cerebral ventricle respectively. After 45 minutes, total cerebral ischemia was given for 10 minutes. Five days later, motor function and behaviors changes of the rats were measured. Then the rats were sacrificed and the samples of brain tissue were obtained for pathology. Results The motor function score in the ACSF group was significantly less than those in the other groups (all P<0.05). There was significant difference in the motor function score among three DADLE groups (all P<0.05). The score in the DAD20 group was the highest one and the score in the DAD2+N group was significantly less than that in the DAD2 group (all P<0.05). The latencies on the 7th and 8th days after brain ischemia in the ACSF group were longer than those of other groups (all P<0.05). There was significant difference in the latency among three DADLE groups (all P<0.05). The latency was the shortest in the DAD20 group. The latency in the DAD2+N group was significantly longer than that in the DAD20 group (P<0.05). There was no significant difference in swimming speed among groups (all P>0.05). In the 6th, 7th and 8th days after brain ischemia, the swimming time spent in the target quadrant in the ACSF group was significantly shorter than those of other groups (all P<0.05), and the differences among three DADLE groups were statistically significant (all P<0.05); DAD20 group had the longest time. The time spent in the target quadrant in the DAD2+N group was significantly shorter than that in the DAD20 group (P<0.05). The survival neurons in the CA1 area of hippocampus in the ACSF group was the least compared with other groups (all P<0.05). The survival neurons had a dose dependent increase in the three DADLE groups (all P<0.05). The survival neurons in the DAD2+N group was significantly less than that in the DAD2 group (P<0.05). Conclusion The administration of DADLE in lateral cerebral ventricle have a dose-dependent neuroprotective effect on severe global brain ischemia in rats, which is mainly due to the activation of delta opioid receptor.

Delta Opioid Peptide (D-ALA 2, D-LEU 5) Enkephalin: Linking Hibernation and Neuroprotection

Dose-dependent neuroprotection of delta opioid peptide [D-Ala2, D-Leu5] enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats.

Delta opioid peptide [D-Ala2, D-Leu5] enkephalin (DADLE) triggers postconditioning against transient forebrain ischemia.

Protective Effects of the Delta Opioid Peptide [d‐ala2, D‐Leu5]enkephalin in an Ex Vivo Model of Ischemia/Reperfusion in Brain Slices

Delta opioid agonist [D-Ala2, D-Leu5] enkephalin (DADLE) reduced oxygen-glucose deprivation caused neuronal injury through the MAPK pathway.

Treatment with Delta Opioid Peptide Enhances in Vitro and in Vivo Survival of Rat Dopaminergic Neurons

Delta Opioid Peptide [D-Ala2, D-Leu5] Enkephalin Confers Neuroprotection by Activating Delta Opioid Receptor-Ampk-autophagy Axis Against Global Ischemia.

Antioxidative and Antiapoptotic Effects of Delta-Opioid Peptide [D-Ala2, D-Leu5] Enkephalin on Spinal Cord Ischemia-Reperfusion Injury in Rabbits

Effects of delta opioid peptide DADLE on ischemic brain injury in rats

Dose-dependent Neuroprotection of Delta-Opioid Peptide [D-Ala(2), D-Leu(5)] Enkephalin on Spinal Cord Ischemia-Reperfusion Injury by Regional Perfusion into the Abdominal Aorta in Rabbits.

Effects of Intracerebroventricular Application of the Delta Opioid Receptor Agonist [D-Ala2, D-Leu5] Enkephalin on Neurological Recovery Following Asphyxial Cardiac Arrest in Rats.

[D-Ala2, D-Leu5] Enkephalin Inhibits TLR4/NF-κB Signaling Pathway and Protects Rat Brains Against Focal Ischemia-Reperfusion Injury

Prolonged DADLE Exposure Epigenetically Promotes Bcl-2 Expression and Elicits Neuroprotection in Primary Rat Cortical Neurons Via the PI3K/Akt/NF-κB Pathway

Delta opioid peptide [D-ala2, D-leu5]-Enkephalin's ability to enhance mitophagy via TRPV4 to relieve ischemia/reperfusion injury in brain microvascular endothelial cells

DADLE promotes motor function recovery by inhibiting cytosolic phospholipase A2 mediated lysosomal membrane permeabilization after spinal cord injury

Protective effect of delta opioid agonist [D-Ala2, D-Leu5] enkephalin on spinal cord ischemia reperfusion injury by regional perfusion into abdominal aorta in rabbits.

Protective Effect of Delta Opioid Receptor Agonist (D-Ala2, D-Leu5) Enkephalin on Permanent Focal Cerebral Ischemia in Rats

D-Ala2, D-Leu5] encephalin (DADLE) reversibly inhibits cellular transcription in neurons without causing cell injury

Delta Opioid Peptide [d-Ala2, d-Leu5]-Enkephalin Improves Physical and Cognitive Function and Increases Lifespan in Aged Female Mice

Role of DADLE Preconditioning on Cardioprotection in Swine after Ischemic-Reperfusion

Utilizing Delta Opioid Receptors and Peptides for Cytoprotection: Implications in Stroke and Other Neurological Disorders